Summary of histologic features, immunophenotype, and molecular analysis of AITL cases
Case no. . | Pattern* . | CD10/ CD3†(%) . | Clear cells‡ . | CD10/ Ki672-153(%) . | TCR PCR . | IgH PCR . |
---|---|---|---|---|---|---|
1 | I | 5 | Absent | O | P | |
2 | I | 5 | Absent | 16 | M | P |
3 | I | 10 | Present | O | P | |
4 | I | 10 | Absent | M | P | |
5 | I | 20 | Present | 8 | M | P |
6 | I | 0 | Absent | M | P | |
7 | II | 5 | Absent | P | P | |
8 | II | 5 | Absent | M | P | |
9 | II | 5 | Absent | 11 | M | P |
10 | II | 10 | Present | 19 | O | P |
11 | II | 10 | Present | M | M | |
12 | II | 15 | Present | M | P | |
13 | II | 20 | Absent | M | M | |
14 | II | 20 | Absent | O | M | |
15A | II | 5 | Absent | M | P | |
15B | III | 5 | Present | M | P | |
16A | II | 0 | Absent | M | P | |
16B | III | 0 | Absent | M | M | |
17 | III | 5 | Present | M | P | |
18 | III | 5 | Present | M | P | |
19 | III | 5 | Present | M | P | |
20 | III | 5 | Present | O | M | |
21 | III | 10 | Absent | M | P | |
22 | III | 10 | Absent | M | P | |
23 | III | 20 | Present | M | P | |
24 | III | 20 | Present | M | NA | |
25 | III | 20 | Present | 10 | M | P |
26 | III | 30 | Absent | 11 | O | P |
27 | III | 30 | Present | 19 | M | M |
28 | III | 30 | Present | M | P | |
29 | III | 30 | Present | O | P | |
30 | III | 0 | Present | M | P |
Case no. . | Pattern* . | CD10/ CD3†(%) . | Clear cells‡ . | CD10/ Ki672-153(%) . | TCR PCR . | IgH PCR . |
---|---|---|---|---|---|---|
1 | I | 5 | Absent | O | P | |
2 | I | 5 | Absent | 16 | M | P |
3 | I | 10 | Present | O | P | |
4 | I | 10 | Absent | M | P | |
5 | I | 20 | Present | 8 | M | P |
6 | I | 0 | Absent | M | P | |
7 | II | 5 | Absent | P | P | |
8 | II | 5 | Absent | M | P | |
9 | II | 5 | Absent | 11 | M | P |
10 | II | 10 | Present | 19 | O | P |
11 | II | 10 | Present | M | M | |
12 | II | 15 | Present | M | P | |
13 | II | 20 | Absent | M | M | |
14 | II | 20 | Absent | O | M | |
15A | II | 5 | Absent | M | P | |
15B | III | 5 | Present | M | P | |
16A | II | 0 | Absent | M | P | |
16B | III | 0 | Absent | M | M | |
17 | III | 5 | Present | M | P | |
18 | III | 5 | Present | M | P | |
19 | III | 5 | Present | M | P | |
20 | III | 5 | Present | O | M | |
21 | III | 10 | Absent | M | P | |
22 | III | 10 | Absent | M | P | |
23 | III | 20 | Present | M | P | |
24 | III | 20 | Present | M | NA | |
25 | III | 20 | Present | 10 | M | P |
26 | III | 30 | Absent | 11 | O | P |
27 | III | 30 | Present | 19 | M | M |
28 | III | 30 | Present | M | P | |
29 | III | 30 | Present | O | P | |
30 | III | 0 | Present | M | P |
TCR indicates T-cell receptor-γ chain gene; PCR, polymerase chain reaction; IgH, immunoglobulin heavy chain gene; M, monoclonal; O, oligoclonal; P, polyclonal; NA, no amplification.
The histologic pattern as described in “Results.”
Percentage of CD10+ and CD3+ T cells.
Cases containing aggregates of atypical lymphoid cells with clear cytoplasm.
Percentage of CD10+ cells expressing Ki67.